- Trials with a EudraCT protocol (14)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (36)
14 result(s) found for: Strabismus.
Displaying page 1 of 1.
| EudraCT Number: 2006-004729-27 | Sponsor Protocol Number: 0504270672 | Start Date*: 2006-09-04 | |||||||||||
| Sponsor Name:Organisation name was not entered | |||||||||||||
| Full Title: Vähentääkö pintapuudutus karsastusleikkauksen aikaista nosiseptiivistä stressivastetta nukutetuilla lapsipotilailla | |||||||||||||
| Medical condition: karsastusleikkaus | |||||||||||||
|
|||||||||||||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: FI (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2020-000280-23 | Sponsor Protocol Number: BISS | Start Date*: 2020-08-20 | ||||||||||||||||
| Sponsor Name:Prof Mathias Abegg | ||||||||||||||||||
| Full Title: A pragmatic, randomized, non-inferiority trial comparing the effectiveness of Botulinum toxin-based treatment with conventional strabismus surgery in acquired esotropia | ||||||||||||||||||
| Medical condition: Acquired esotropia (strabismus) | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
| Trial protocol: FR (Ongoing) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2010-023216-14 | Sponsor Protocol Number: HP-AM2-001 | Start Date*: 2011-03-15 | ||||||||||||||||||||||||||
| Sponsor Name:Hermo Pharma Ltd | ||||||||||||||||||||||||||||
| Full Title: A Phase II, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Study of 10 Weeks Treatment with Fluoxetine 20 mg and Computer Software-Based Training in Adult Patients with Amblyopia | ||||||||||||||||||||||||||||
| Medical condition: treatment of adult amblyopia - amblyopia due to myopic or hyperopic anisometropia, or, congenital esotropia. | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||
| Trial protocol: FI (Completed) EE (Completed) | ||||||||||||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||||||||||||
| EudraCT Number: 2006-004811-22 | Sponsor Protocol Number: ABR 14357 | Start Date*: 2008-04-01 | |||||||||||
| Sponsor Name:Erasmus Medical Center Rotterdam | |||||||||||||
| Full Title: A prospective, randomized, double-blind comparison of 5 % against 1 % povidone-iodine solution in preoperative antisepsis for strabismus surgery in young children. | |||||||||||||
| Medical condition: Endophthalmitis (E) after strabismus surgery (S) leading to blindness is caused by eyelid and conjunctival bacteria. Povidone-iodine(PI) solutions between 1% and 5% reduce the number of bacteria on... | |||||||||||||
|
|||||||||||||
| Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2019-004501-27 | Sponsor Protocol Number: 2183/2019 | Start Date*: 2021-01-28 |
| Sponsor Name:Medical University of Vienna | ||
| Full Title: Perioperative analgesia in children undergoing ophthalmic surgery | ||
| Medical condition: perioperative analgesia | ||
| Disease: | ||
| Population Age: Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-000810-44 | Sponsor Protocol Number: FSJD-PMM2-2016 | Start Date*: 2017-05-31 | |||||||||||
| Sponsor Name:Fundació Sant Joan de Déu | |||||||||||||
| Full Title: Phase II clinical trial to evaluate the effectiveness and safety of acetazolamide in the treatment of cerebellar syndrome in patients with PMM2-CDG deficiency. | |||||||||||||
| Medical condition: Cerebellar syndrome | |||||||||||||
|
|||||||||||||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2010-021022-35 | Sponsor Protocol Number: 0908125 | Start Date*: 2010-10-12 | ||||||||||||||||
| Sponsor Name:CHU de Saint-Etienne | ||||||||||||||||||
| Full Title: Effet of curarization under general anaesthesia on eye movements in non-strabismus children | ||||||||||||||||||
| Medical condition: Healthy volunteer who will have a surgery requiring curare administration (amygdalectomy...) | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
| Trial protocol: FR (Completed) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2011-000157-23 | Sponsor Protocol Number: version1.1SFINX | Start Date*: 2011-09-27 |
| Sponsor Name:UMC St Radboud | ||
| Full Title: Street Fitness In surgical patieNts undergoing general anesthesia after reversal of neuromuscular rest blockade with sugammadeX (SFINX study) | ||
| Medical condition: Males and females in the age of 18-65 undergoing minor surgery/gynaecological procedures with a medical need for general anesthesia and neuromuscular blockade will be included in the study. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2011-000899-33 | Sponsor Protocol Number: rescue RTX | Start Date*: 2011-08-09 |
| Sponsor Name:Department of Endocrinology, Sahlgrenska University Hospital | ||
| Full Title: Rituximab (RTX) therapy in steroid resistant patients or patients relapsing after intravenous steroids with active TAO Rescue RTX | ||
| Medical condition: Thyroid associated opthalmopathy | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2011-006006-27 | Sponsor Protocol Number: 0869-219 | Start Date*: 2012-11-05 | |||||||||||
| Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc | |||||||||||||
| Full Title: A Phase IIb, Partially-Blinded, Randomized, Active Comparator-Controlled Study to Evaluate the Pharmacokinetics/Pharmacodynamics, Safety, and Tolerability of Aprepitant in Pediatric Patients for th... | |||||||||||||
| Medical condition: Post Operative Nausea and Vomiting in surgical patients | |||||||||||||
|
|||||||||||||
| Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: HU (Completed) ES (Completed) CZ (Completed) IT (Completed) Outside EU/EEA | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2010-022971-79 | Sponsor Protocol Number: PALO-10-14 | Start Date*: 2011-05-23 | ||||||||||||||||
| Sponsor Name:Helsinn Healthcare SA | ||||||||||||||||||
| Full Title: A Multicenter, Double-blind, Double-dummy, Randomized, Parallel Group, Stratified Study to Evaluate the Efficacy and Safety of a Single IV Dose of Palonosetron Compared to a Single IV Dose of Ondan... | ||||||||||||||||||
| Medical condition: Postoperative nausea and vomiting (PONV) | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
| Trial protocol: CZ (Completed) PL (Completed) HU (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2013-005017-12 | Sponsor Protocol Number: EyeADHD-01 | Start Date*: 2014-03-31 | |||||||||||
| Sponsor Name:Parnassia Bavo Groep - PsyQ | |||||||||||||
| Full Title: Looking into the eye of ADHD. Investigating the relationship between ADHD, the delayed circadian rhythm and the functioning of the eye. | |||||||||||||
| Medical condition: Adults with ADHD and suboptimal eye functioning. | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2018-004058-11 | Sponsor Protocol Number: RM-493-023 | Start Date*: Information not available in EudraCT |
| Sponsor Name:Rhythm Pharmaceuticals, Inc. | ||
| Full Title: A Phase 3 trial of Setmelanotide (RM-493), a Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström syndrome (AS) Patients with Moderate to Severe Obesity | ||
| Medical condition: Obesity and hyperphagia in patients with Bardet-Biedl Syndrome or Alström syndrome | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: FR (Completed) ES (Completed) GB (GB - no longer in EU/EEA) | ||
| Trial results: View results | ||
| EudraCT Number: 2017-001215-37 | Sponsor Protocol Number: RG_16_211 | Start Date*: 2018-03-19 |
| Sponsor Name:University of Birmingham | ||
| Full Title: A pivotal, international, randomised, double-blind, efficacy and safety trial of sodium valporate in paediatric and adult patients with Wolfram Syndrome | ||
| Medical condition: Wolfram syndrome | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: GB (GB - no longer in EU/EEA) PL (Completed) FR (Completed) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.